A Single-center, Randomized, Double-blind, Two-period Cross-over Study to Investigate the Effect of Rifampicin on the Pharmacokinetics of Clazosentan in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2018
At a glance
- Drugs Clazosentan (Primary) ; Rifampicin
- Indications Cerebral vasospasm
- Focus Pharmacokinetics
- Sponsors Idorsia Pharmaceuticals
- 22 Oct 2018 Status changed from recruiting to completed.
- 30 Aug 2018 Status changed from not yet recruiting to recruiting.
- 26 Jul 2018 New trial record